Senate, House consider the future of compounding pharmacies
Last year, the New England Compounding Center in Massachusetts made a tainted drug. It led to 55 deaths and 700 cases of fungal meningitis. The outbreak prompted plenty of legal action, but little on the legislative front.
Emily Ethridge, staff writer for CQ Roll Call, offered an update on Capital Insider.